Search Results - "Oelmann, E.M."

455MO NUC-7738 in patients with advanced solid tumours: Phase I results from the NuTide:701 phase I/II study by Symeonides, S.N., Skolariki, A., Haris, N.R.M., Boh, Z., Myers, M., Oelmann, E.M., Bloss, J.D., Plummer, R., Blagden, S.P.

Get full text

354P NUC-3373, a ProTide transformation of 5-FU, in combination with oxaliplatin (NUFOX) or irinotecan (NUFIRI) in patients with advanced colorectal cancer (CRC) (NuTide:302) by Coveler, A., Skolariki, A., Ciombor, K.K., Marijon Jourdier, H., Graham, J., Peters, M.L., Cohen, S.A., Myers, M., Oelmann, E.M., Bloss, J., Blagden, S.P., de Gramont, A., Berlin, J.D., Evans, T.R.J.

Get full text